The new year ushers in a brand new homepage for Microsoft Academic, as a sign of exciting developments to come. We released the new homepage to let you, our users, know that we are working on a major redesign of…
| Sandy Blyth
Class of 2018-19 PhD fellows to push frontiers of AI By Sandy Blyth A graduate student working on technology that leverages human brain signals to accelerate robot learning and another student who is developing models of human conversations that capture…
In the news | The Register
Microsoft has switched on new network interface cards packing field-programmable gate arrays and announced that doing so has let it hit 30Gbps of throughput for servers in Azure.
In the news | The Frontiers of Artificial Intelligence: Deep learning brings speed, accuracy to the life sciences
In the news | Microsoft Azure Blog
We are happy to announce that Accelerated Networking (AN) is generally available (GA) and widely available for Windows and the latest distributions of Linux providing up to 30Gbps in networking throughput, free of charge! AN provides consistent ultra-low network latency via…
In the news | GeekWire
The human immune system is incredibly complex and incredibly smart. Your immune system knows when you’re getting sick, sometimes days, months or even years before the problem is diagnosed.
In the news | Fast Company
Microsoft and Adaptive Biotechnologies hope to pair advances in AI and machine learning with recent breakthroughs in biotechnology to map out the immune system and tap into the body's impressive diagnostic system.
In the news | siliconrepublic
The aim is to create a single blood test that could be trained to identify potentially hundreds of illnesses in the immune system before they present themselves as symptoms.
In the news | Healthcare IT News
Microsoft and Adaptive Biotechnologies announced a joint arrangement to leverage artificial intelligence and machine learning with biotechnologies to ultimately decode the human immune system. The deal follows Microsoft and Google each investing in precision medicine startup DNAnexus earlier this week…